Drug sales growth in major world markets

12 REGULATORY & HEALTHCARE NEWS Drug sales growth in major world markets Drug sales through retail pharmacies grew 6% to $USI85.4 billion in 1998 in the 12 major world markets, reports Marketletter. According to an IMS Health report, growth over the 12-month period remained stable in North America at 11 % (market value $US78.4 billion) and in the top 5 European markets at 7% (combined value $US52.4 billion). The Japanese market (valued at $US38.8 billion) has also stabilised at a declining rate of 1% per 12-month period. In Latin America, the growth rate declined from 3 to 2%, with Mexico having the largest decrease from 14 to 11 %. In the US, genitourinary drugs represented the drug class with the fastest growing market (up 19%). This rise was due to the performance of the urological drugs, including sildenafil ['Viagra'], which rose 124% over the 12 months to December 1998. 6% Growth in top 12 phanna markets. Marketletter 26: 16,8 Mar 1999 80074163. PhannacoEconomics & CNIcom<Is News 20 Mar 1_ No. 204 1173-5503199/0204-000121$01 . 00" Adla lnl8mationlll Limited 1_. All rlghta r8MrVed

Upload
esperanza
Category

Documents
view
213
download
1

Embed Size (px):

Transcript of Drug sales growth in major world markets

12 REGULATORY & HEALTHCARE NEWS

Drug sales growth in major world markets

Drug sales through retail pharmacies grew 6% to $USI85.4 billion in 1998 in the 12 major world markets, reports Marketletter.

According to an IMS Health report, growth over the 12-month period remained stable in North America

at 11 % (market value $US78.4 billion) and in the top 5 European markets at 7% (combined value $US52.4 billion). The Japanese market (valued at $US38.8 billion) has also stabilised at a declining rate of 1 % per 12-month period. In Latin America, the growth rate declined from 3 to 2%, with Mexico having the largest decrease from 14 to 11 %.

In the US, genitourinary drugs represented the drug class with the fastest growing market (up 19%). This rise was due to the performance of the urological drugs, including sildenafil ['Viagra'], which rose 124% over the 12 months to December 1998.

6% Growth in top 12 phanna markets. Marketletter 26: 16,8 Mar 1999 80074163.

PhannacoEconomics & CNIcom<Is News 20 Mar 1_ No. 204 1173-5503199/0204-000121$01 .00" Adla lnl8mationlll Limited 1_. All rlghta r8MrVed